2-(4-(Trifluoromethoxy)phenoxy)propanehydrazide, 97%, 1g

{2-[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]ethyl}amine hydrochloride hydrate, 95.0%, 1g

5-Bromo-2-chloro-4-hydroxypyridine, 95.0%, 250mg

2-Chloro-4-iodo-3-methoxypyridine, 98%, 250mg

3-Hydroxy-4-methylbenzoic acid, min. 98%, for synthesis, 5 g, plastic packaging.

(R)-1-(3-Fluorophenyl)ethanol, 95.0%, 10g

tert-butyl 2-methyl-3-(propylamino)propanoate, 95.0%, 10g

N-Boc-3-Carboethoxy-4-piperidone, 95.0%, 25g

(5S,8S,11S,12R)-11-((S)-sec-Butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oic acid, 98%, 5g

(5-Bromo-2-chloro-phenyl)-hydrazine, 95.0%, 1g

3-Methoxypropyl 2-cyanoacetate, 98%, 500mg

TLC Plates CEL 300 / UV254, 10 x 20 cm, 50 Piece(s)

2,6-Dibromo-1,5-dihydroxynaphthalene>93.0%(T)25g